MLTX vs. QQQ
Compare and contrast key facts about MoonLake Immunotherapeutics (MLTX) and Invesco QQQ (QQQ).
QQQ is a passively managed fund by Invesco that tracks the performance of the NASDAQ-100 Index. It was launched on Mar 10, 1999.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MLTX or QQQ.
Performance
MLTX vs. QQQ - Performance Comparison
Returns By Period
In the year-to-date period, MLTX achieves a -10.05% return, which is significantly lower than QQQ's 24.04% return.
MLTX
-10.05%
16.59%
32.97%
19.89%
N/A
N/A
QQQ
24.04%
3.57%
10.78%
30.56%
20.99%
18.03%
Key characteristics
| MLTX | QQQ | |
|---|---|---|
| Sharpe Ratio | 0.39 | 1.76 |
| Sortino Ratio | 0.91 | 2.35 |
| Omega Ratio | 1.11 | 1.32 |
| Calmar Ratio | 0.50 | 2.25 |
| Martin Ratio | 0.80 | 8.18 |
| Ulcer Index | 24.95% | 3.74% |
| Daily Std Dev | 50.77% | 17.36% |
| Max Drawdown | -64.60% | -82.98% |
| Current Drawdown | -14.94% | -1.62% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between MLTX and QQQ is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
MLTX vs. QQQ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for MoonLake Immunotherapeutics (MLTX) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MLTX vs. QQQ - Dividend Comparison
MLTX has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.60%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MLTX MoonLake Immunotherapeutics | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QQQ Invesco QQQ | 0.60% | 0.62% | 0.80% | 0.43% | 0.55% | 0.74% | 0.91% | 0.84% | 1.06% | 0.99% | 1.41% | 1.02% |
Drawdowns
MLTX vs. QQQ - Drawdown Comparison
The maximum MLTX drawdown since its inception was -64.60%, smaller than the maximum QQQ drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for MLTX and QQQ. For additional features, visit the drawdowns tool.
Volatility
MLTX vs. QQQ - Volatility Comparison
MoonLake Immunotherapeutics (MLTX) has a higher volatility of 15.02% compared to Invesco QQQ (QQQ) at 5.36%. This indicates that MLTX's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.